These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Actions of sparteine and sparteine derivatives on the heart and circulation]. Raschack M Arzneimittelforschung; 1974 May; 24(5):753-9. PubMed ID: 4408029 [No Abstract] [Full Text] [Related]
46. [Kinetics of the blocking action of antifibrillatory drugs on sodium channels in myocardial fibers]. Heistracher P; Thaler E; Liebeswar G Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):351-2. PubMed ID: 4253791 [No Abstract] [Full Text] [Related]
47. [Electrocardiogram or unanesthetized dogs in acute and chronic toxicity studies on orally administered N-(n-propyl)-ajmalinium-hydrogentartrate]. von Philipsborn G Arzneimittelforschung; 1972 Feb; 22(2):441-5. PubMed ID: 5067911 [No Abstract] [Full Text] [Related]
48. [Effect of mexiletine on the excitability and vulnerability of the dog ventricle (author's transl)]. Márquez Montes J; Vera Almazán A; Esteve Alderete JJ; Puente Rodero B; Montero C; Castillo-Olivares JL Arch Farmacol Toxicol; 1981 Dec; 7(3):307-18. PubMed ID: 7337470 [No Abstract] [Full Text] [Related]
49. Antiarrhythmic effect of manganese chloride in infarcted dogs with observations on the dose-related response of heart rate and ventricular pressure. Kligfield P; Charash B; Placek E; Sos TA J Pharmacol Exp Ther; 1981 Jul; 218(1):289-95. PubMed ID: 7241386 [No Abstract] [Full Text] [Related]
50. [Effect of Rauwolfia serpentina on the glycemic curve of the glucose tolerance test in normal subject & diabetics]. CAZZAROLI L; DALL'OGLIO D Prog Med (Napoli); 1958 Jan; 14(2):52-6. PubMed ID: 13527550 [No Abstract] [Full Text] [Related]
51. [Rauwolfia serpentina, acetylcholine and histamine]. Vincent D; Segonzac G Pathol Biol; 1958 Jan; 6(1-2):59-70. PubMed ID: 13578432 [No Abstract] [Full Text] [Related]
52. [The topological characteristics of rat myocardial reactivity to noradrenaline, acetylcholine and a change in the electrostimulation frequency]. Dudka SB; Kaz'min SH Fiziol Zh (1978); 1992; 38(4):19-27. PubMed ID: 1286685 [TBL] [Abstract][Full Text] [Related]
53. [Action of 17-monochloro-acetylajmaline, a new anti-arrhythmia drug, upon myocardial contractility]. Bardet J; Roudy G; Rocha P; Riguad M; Mathivat A; Bourdarias JP Ann Cardiol Angeiol (Paris); 1974; 23(6):539-44. PubMed ID: 4618072 [No Abstract] [Full Text] [Related]
54. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent. Watanabe Y; Dreifus LS J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942 [No Abstract] [Full Text] [Related]
55. The separation and identification of microquantities of Rauwolfia alkaloids. Habib MS; Court WE Planta Med; 1974 Jun; 25(4):331-41. PubMed ID: 4855084 [No Abstract] [Full Text] [Related]
56. The cardiac action of lysolecithin. Govier WC; Boadle MC J Pharmacol Exp Ther; 1967 May; 156(2):339-44. PubMed ID: 4381703 [No Abstract] [Full Text] [Related]
57. [Comparison of atrial and ventricular sensitivity to anti-arrhythmia agents--sodium current blockers]. Grenader AK; Ponomareva VM; Vasiev BN Kardiologiia; 1983 May; 23(5):90-1. PubMed ID: 6308325 [No Abstract] [Full Text] [Related]